Cargando…

Prevalence of metabolic syndrome in type 2 diabetes mellitus patients

BACKGROUND: The diabetic condition is influenced by several factors, some of which can accelerate the disease's progression to various complications that aggravate the morbidity. AIMS: This study aimed at determining the prevalence of metabolic syndrome (MetS) and its individual components and...

Descripción completa

Detalles Bibliográficos
Autores principales: Nsiah, Kwabena, Shang, V Owusua, Boateng, K Agyenim, Mensah, FO
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4456889/
https://www.ncbi.nlm.nih.gov/pubmed/26097823
http://dx.doi.org/10.4103/2229-516X.157170
_version_ 1782374907214036992
author Nsiah, Kwabena
Shang, V Owusua
Boateng, K Agyenim
Mensah, FO
author_facet Nsiah, Kwabena
Shang, V Owusua
Boateng, K Agyenim
Mensah, FO
author_sort Nsiah, Kwabena
collection PubMed
description BACKGROUND: The diabetic condition is influenced by several factors, some of which can accelerate the disease's progression to various complications that aggravate the morbidity. AIMS: This study aimed at determining the prevalence of metabolic syndrome (MetS) and its individual components and the most critical predictive risk factors of MetS in type 2 diabetic patients. MATERIALS AND METHODS: This cross-sectional study involved 150 type 2 diabetes mellitus patients and was conducted at the Diabetes Centre of the Komfo Anokye Teaching Hospital in Kumasi, the Ashanti Region of Ghana, from February, 2013 to April, 2013. The study involved the use of a questionnaire to obtain some information on the diabetics, undertaking anthropometric measurements, as well as collecting blood samples for the measurement of some biochemical parameters; fasting blood glucose and lipid profile. MetS was defined according to the National Cholesterol Education Program/Adult Treatment Panel III criteria. RESULTS: The prevalence of MetS was 58% in the studied Ghanaian population. Hypertension was the commonest risk factor (60%), followed by central obesity (48.67%) and dyslipidemia (37%). Female type 2 diabetics had a higher prevalence of MetS, and carried more components than their male counterparts. Regression analysis showed three factors; femininity, high body mass index and low educational status were the most critical predictive risk factors of MetS, according to this study. CONCLUSION: With hypertension being the commonest component, future cardiovascular disease prevention strategies should focus attention on its management and prevention, through education.
format Online
Article
Text
id pubmed-4456889
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-44568892015-06-19 Prevalence of metabolic syndrome in type 2 diabetes mellitus patients Nsiah, Kwabena Shang, V Owusua Boateng, K Agyenim Mensah, FO Int J Appl Basic Med Res Original Article BACKGROUND: The diabetic condition is influenced by several factors, some of which can accelerate the disease's progression to various complications that aggravate the morbidity. AIMS: This study aimed at determining the prevalence of metabolic syndrome (MetS) and its individual components and the most critical predictive risk factors of MetS in type 2 diabetic patients. MATERIALS AND METHODS: This cross-sectional study involved 150 type 2 diabetes mellitus patients and was conducted at the Diabetes Centre of the Komfo Anokye Teaching Hospital in Kumasi, the Ashanti Region of Ghana, from February, 2013 to April, 2013. The study involved the use of a questionnaire to obtain some information on the diabetics, undertaking anthropometric measurements, as well as collecting blood samples for the measurement of some biochemical parameters; fasting blood glucose and lipid profile. MetS was defined according to the National Cholesterol Education Program/Adult Treatment Panel III criteria. RESULTS: The prevalence of MetS was 58% in the studied Ghanaian population. Hypertension was the commonest risk factor (60%), followed by central obesity (48.67%) and dyslipidemia (37%). Female type 2 diabetics had a higher prevalence of MetS, and carried more components than their male counterparts. Regression analysis showed three factors; femininity, high body mass index and low educational status were the most critical predictive risk factors of MetS, according to this study. CONCLUSION: With hypertension being the commonest component, future cardiovascular disease prevention strategies should focus attention on its management and prevention, through education. Medknow Publications & Media Pvt Ltd 2015 /pmc/articles/PMC4456889/ /pubmed/26097823 http://dx.doi.org/10.4103/2229-516X.157170 Text en Copyright: © International Journal of Applied and Basic Medical Research http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Nsiah, Kwabena
Shang, V Owusua
Boateng, K Agyenim
Mensah, FO
Prevalence of metabolic syndrome in type 2 diabetes mellitus patients
title Prevalence of metabolic syndrome in type 2 diabetes mellitus patients
title_full Prevalence of metabolic syndrome in type 2 diabetes mellitus patients
title_fullStr Prevalence of metabolic syndrome in type 2 diabetes mellitus patients
title_full_unstemmed Prevalence of metabolic syndrome in type 2 diabetes mellitus patients
title_short Prevalence of metabolic syndrome in type 2 diabetes mellitus patients
title_sort prevalence of metabolic syndrome in type 2 diabetes mellitus patients
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4456889/
https://www.ncbi.nlm.nih.gov/pubmed/26097823
http://dx.doi.org/10.4103/2229-516X.157170
work_keys_str_mv AT nsiahkwabena prevalenceofmetabolicsyndromeintype2diabetesmellituspatients
AT shangvowusua prevalenceofmetabolicsyndromeintype2diabetesmellituspatients
AT boatengkagyenim prevalenceofmetabolicsyndromeintype2diabetesmellituspatients
AT mensahfo prevalenceofmetabolicsyndromeintype2diabetesmellituspatients